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Summary.-Three dihydrodiols that are metabolites of benzo[a]pyrene and benzo[a]-
pyrene itself have been tested in a comparative experiment for their activities as
initiators of tumours in mouse skin. A single application (25 ,ug) of 4,5-dihydro-
4,5-dihydroxybenzo[a]pyrene, of 7,8-dihydro-7,8-dihydroxybenzo[a]pyrene, of 9,10-
dihydro-9,10-dihydroxybenzo[a]pyrene, or of benzo[a]pyrene was made to the shaved
dorsal skin of adult female CDI mice; this was followed 2 weeks later by multiple
thrice- or twice-weekly applications (1 ,ug) of 12-O-tetradecanoyl-phorbol-13-acetate
as promoting agent. A control group of30 mice received the promoting agent alone.
The experiments were terminated 52 weeks after initiation. At this stage, all the
groups contained mice bearing skin papillomas, some of which had progressed to
malignancy. Quantitatively the results show that the 7,8-dihydrodiol is almost as
active an initiator of mouse skin tumours as benzo[a]pyrene itself; the 4,5- and 9,10-
dihydrodiols were significantly less active. The significance of these results is
discussed in relation to the hypothesis that diol-epoxides are important in the
metabolic activation of polycyclic hydrocarbons like benzo[a]pyrene.
THE INITIAL EVIDENCE showing that
the metabolic activation ofbenzo[a]pyrene
(formula shown) involved the formation of
7,8-dihydro-7, 8-dihydroxybenzo[a]pyrene
9,10-oxide was obtained with hamster
embryo cells in culture (Sims et al., 1974)
and the mechanism appears to be similar
in mouse skin. Thus, spectrophotofluori-
metric studies indicated that metabolism
of the 7,8,9,10-ring was involved in the
activation of benzo[a]pyrene in mouse
skin (Daudel et al., 1975) and the chroma-
tographic characteristics of the benzo[a]-
pyrene-deoxyribonucleoside products that
are formed in mouse skin treated with the
hydrocarbon were recently found to be
the same as those of the deoxyribonucleo-
side products that are formed when
7,8-dihydro-7, 8-dihydroxybenzo[a]pyrene
9,10-oxide reacts with DNA in solution
(Grover et al., 1976). This is in agreement
with the general idea that the further
metabolism of the olefinic double bonds
present in non-K-region dihydrodiols can
yield diol-epoxides (Booth and Sims, 1974)
that react with DNA in vivo. The
biological activity of non-K-region dihy-
drodiols in situations where they can be
further metabolized is, therefore, of in-
terest. Some non-K-region dihydrodiols
are more active in the induction of
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malignant transformation in mouse fibro-
blasts than the parent hydrocarbons
(Marquardt, Grover and Sims, 1976) and
they can also induce more mutations,
when metabolized by microsomal prepara-I. CHOUROULINKOV, A. GENTIL, P. L. GROVER AND P. SIMS
tions in the presence of S. typhimurium
TA100 (Malaveille et at., 1975).
One method of examining the carcino-
genic activity of metabolites that are only
available in small amounts is to test them
for initiating activity on mouse skin that
is then treated with a promoting agent
(Berenblum and Shubik, 1947a, b; Beren-
blum, 1974). This paper presents the
results that were obtained when benzo[a]-
pyrene and the related 4,5-, 7,8- and 9,10-
dihydrodiols were tested for initiating
activity by applying them, as a single dose,
to the dorsal skin of adult, female, CDI
mice; the appearance of tumours was
promoted by subsequent multiple appli-
cations of 12-0-tetradecanoyl-phorbol- 13-
acetate.
MATERIALS AND METHODS
Female 43-day-old CDI mice (Charles
River, France) that had been vaccinated
against ectromelia 14 days earlier, were
randomized into groups of 30. The animals
were then housed in individual cages for the
duration of the experiments in order to
prevent inter-mouse licking.
Benzo[a]pyrene (Sigma Chemical Co, St
Louis, Mo, U.S.A.) was purified by column
chromatography on alumina and recrystal-
lization. The K-region dihydrodiol, trans-4,
5-dihydroxybenzo[a]pyrene was prepared
from the corresponding cis-isomer (Sims,
1970a). The non-K-region dihydrodiols, 7,8-
dihydro-7,8-dihydroxybenzo[a]pyrene and
9, 10-dihydro-9, 10-dihydroxybenzo[a]pyrene,
which were obtained, presumably as the
trans-isomers, from large scale incubations of
benzo[a]pyrene with rat-liver homogenates
(Sims, 1970b), werepurified bythin-layer chro-
matography on silica gel (Sims, 1970b) and by
high-pressure liquid chromatography (Holder
et al., 1974) and were characterized by their
chromatographic and u.v. spectral properties.
12-O-tetradecanoyl-phorbol-13-acetate (TPA)
was very kindly donated by Professor E.
Hecker, Heidelburg, Germany.
Treatment
Initiation.-A single dose (25 ,ug) of
benzo[a]pyrene, or of one of the three
benzo[a]pyrene dihydrodiols, was applied as
a solution in acetone (0 05 ml) to the dorsal
skin of mice that had been closely clipped
48 h earlier.
Promotion.-Treatment with phorbol ester
(TPA) was started 2 weeks after the appli-
cation ofthe initiator. For the first 10 weeks
of promotion, TPA (1 ,ug) was applied thrice
weekly as a solution in acetone (0.05 ml) and,
for the following 42 weeks, was applied twice
weekly. The total dose of TPA applied to
the dorsal skin of each mouse was 114 ,ug.
All the treatments with initiators and
promoters were made with the aid of an
accurate automatic microvolumetric dis-
penser. The animals were examined regu-
larly, and the times of appearance of cuta-
neous tumours, both papillomas and malig-
nant neoplasms, were recorded. Systematic
postmortem and histological examinations
were performed on all animals.
RESULTS
Skin tumour morphology
The tumours seen in the areas of
treated skin were papillomas and malig-
nant neoplasms (Fig. la). The papillomas
were included in the results as soon as they
were palpable and clearly visible. At this
stage they were around 2-3 mm in dia-
meter but they commonly reached 1 cm
in diameter. In most cases, malignant
transformation of papillomas was accom-
panied by ulceration (Fig. la).
Histologically, the papillomas showed
anepidermal proliferation that was accom-
panied by hyperkeratinization (Fig. lb).
The malignant neoplasms were squamous
cell carcinomas (Fig. 2 and 3a), which
showed invasion ofthe muscle layer ofthe
skin, and fibrosarcomas (Fig. 3b). One
mixed-cell tumour, an epithelio-sarcoma,
was also seen.
Skin tumour incidence
Skin tumours started to appear about
10 weeks after initiation of the mice;
detailed data on the time of tumour
appearance and on the numbers of mice
with tumours in each group are shown in
Table I. The first papillomas appeared
at about the same time in the 3 groups
initiated with the different benzo[a]pyrene
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FIG. 1 (a).-Macroscopic aspects of skin tumours induced after initiation with 7,8-dihydro-7,8- dihydroxybenzo[a]pyrene (Mice Nos. 10 and 12) and 9,10-dihydro-9,10-dihydroxybenzo[a]pyrene (Mouse No. 34) Papillomas (1), a squamous cell carcinoma (2) and a sarcoma (3) are present. (b) Double papilloma present on mouse skin (Mouse No. 12). There is no invasion of the muscle layer (stratum carnosum) (t ). x 25.
dihydrodiols but, with benzo[a]pyrene
itself, they appeared somewhat earlier
(Table I). In the groups ofmice initiated
with benzo[a]pyrene or with the 7,8-
dihydrodiol, the tumour incidence sub-
sequently increased sharply up to about
27 weeks after initiation, but did not
increase thereafter (Table I). Skin tum-
our incidence in the mice initiated with
the 4,5 and 9,10-dihydrodiols derived
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FiG. 2. Histology of a squamous cell carcinoma induced by 7,8-dihydro-7,8-dihydroxybenzo[a]-
pyrene on mouse skin. (a) General appearance ( x 40). (b) Higher magnification ( x 100) of a
portion of a, showing involvement of the muscle layer (t ). (The tumour is that shown on Mouse
No. 10 in Fig. la).
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FIG. 3 (a).-Dedifferentiated squamous cell carcinoma showing invasion of the stratum carnosum
( x 100). Initiator: benzo[a]pyrene. (b). Subcutaneous fibroscarcoma ( x 100). The tumourwas initiated with 7,8-dihydro-7,8-dihydroxybenzo[a]pyrene and is that shown macroscopically on
Mouse No. 12 in Fig. la.
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from benzo[a]pyrene increased more slowly
up to around 34 weeks after initiation,
and did not increase in the succeeding
18 weeks.
The data on the numbers of animals
that developed tumours (Table I) and on
numbers of tumours present in these
animals (Table II) show that, of the
compounds tested, benzo[a]pyrene has a
slightly more powerful initiating action
than the 7,8-dihydrodiol at the particular
dose used in these experiments, but
application of the X2 test shows that this
difference is not statistically significant
(P > 0.05). The difference between the
tumour-initiating activities of the 4,5-
dihydrodiol and of the 9,10-dihydrodiol is
again not statistically significant (P >
0.05), but the tumour-initiating activities
of benzo[a]pyrene itself and of the 7,8-
dihydrodiol are significantly higher than
those of either the 4,5-dihydrodiol (P <
0U01; P < 0u01) or the 9,10-dihydrodiol
(P < 0 01; P < 0. 05).
The numbers of skin papillomas re-
corded as present in the different groups
of mice (Table I) occasionally show
decreases, that are associated with either
(a) the regression of a papilloma, (b) the
coalescing of 2 adjacent papillomas or (c)
the progression of a papilloma into a
malignant tumour, phenomena that are
known to occur in studies of two-stage
carcinogenesis in mouse skin (Berenblum,
1974). In the control group of mice that
were treated with TPA alone, one skin
papilloma appeared at 18 weeks, but then
regressed (Table I). After about 34 weeks
of treatment with TPA alone, other
papillomata developed in this group of
mice; this was not entirely unexpected, in
view of the known ability of TPA to act
as a weak but complete carcinogen
(Chouroulinkov and Lazar, 1974).
DISCUSSION
The comparative experiments on the
initiating activity, in mouse skin, of
dihydrodiols related to benzo[a]pyrene
were terminated 52 weeks after the single
application of an initiator, because the
numbers of skin tumour in the groups of
initiated mice were no longer increasing,
because the incidence of skin tumours in
the group of mice that were being treated
with the promoting substance alone was
starting to increase and because the
objective of the experiments had been
achieved.
The data on mouse skin tumour
incidence that has been obtained (Tables
I and II) show that, at the particular
dosage level used, 7,8-dihydro-7,8-
dihydroxybenzo[a]pyrene is as active an
initiator as benzo[a]pyrene itself and that
these 2 compounds are distinctly more
active than either 4,5-dihydro-4,5-
dihydroxybenzo[a]pyrene or 9,10-dihydro-
9,10-dihydroxybenzo[a]pyrene. The pro-
moting agent used in these experiments,
12-0-tetradecanoyl-phorbol-13-acetate,in-
duced some skin papillomas when applied
alone, but these only started to appear in
any number towards the end of the
experiment, when the numbers oftumours
arising in the other groups of mice that
had been initiated with a hydrocarbon had
already reached a plateau.
The biological activity of the 7,8-
dihydrodiol in mouse skin was not entirely
unexpected, since this compound has
already been shown to be more active than
benzo[a]pyrene in inducing malignant
transformation of mouse fibroblasts in
culture (Marquardt, Grover and Sims,
1976) and in inducing mutations in S.
typhimurium TA 100 when incubated in
the presence of a microsomal mono-
oxygenase (Malaveille etal., 1975). Appli-
cation of the 7,8-dihydrodiol to mouse
skin also leads to the formation of hydro-
carbon-DNA products that are indistin-
guishable when examined by spectro-
photofluorimetry (Daudel et al., 1975) and
by LH20 Sephadex column chromato-
graphy (Grover et al., 1976) both from
those hydrocarbon-DNA products that
are formed when benzo[a]pyrene itself is
applied to mouse skin and from those that
are formed when 7,8-dihydro-7,8-
dihydroxy-benzo[a]pyrene 9,10-oxide re-
acts with DNA in solution. Polycyclic
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hydrocarbon dihydrodiols that possess
adjacent olefinic double bonds can be
further metabolized by rat-liver micro-
somal mono-oxygenases to this type of
vicinal diol-epoxide (Booth and Sims,
1974) and, presumably, the 7,8-diol can
also be metabolized in mouse skin to the
related diol-epoxide, by microsomal oxi-
dation ofthe 9,10-bond. Recent evidence
obtained with benzo[a]pyrene suggests,
however, that the metabolic pathways
employed forthe further metabolism ofthe
7,8- and 9,10-dihydrodiols are different.
The principal product that was detected
when the 7,8-dihydrodiol was incubated
with a rat-liver microsomal preparation
was the corresponding 7,8,9,10-tetrahydro-
tetrol, that most probably arises from the
sequential action ofthe microsomal mono-
oxygenase and epoxide hydratase upon
the 9,10-bond. With the 9,10-dihydro-
diol, only a small proportion was meta-
bolized via a diol-epoxide to the tetra-
hydrotetrol; in this case the principal
product appeared to be the catechol, 9,10-
dihydroxybenzo[a]pyrene (Booth and
Sims, 1976). These 2 dihydrodiols may
also be further metabolized by different
major pathways in mouse skin, and this
could explain the lower incidence of skin
tumours obtained in the present experi-
ments in the group of mice treated with
the 9,10-dihydrodiol, compared with the
incidence in those treated with the 7,8-
dihydrodiol. In other experiments, in
which the 9,10-dihydrodiol was applied to
mouse skin at a somewhat higher dose,
hydrocarbon-DNA products of the type
that are formed following treatment with
benzo[a]pyrene were not detected (Grover
et al., 1976). The 9,10-dihydrodiol was
also appreciably less active than both the
7,8-dihydrodiol and benzo[a]pyrene itself
in inducing malignant transformation in
mouse fibroblasts (Marquardt et al., 1976)
and mutations in S. typhimurium TA100
(Malaveille et al., 1975). In both cases,
further metabolism of the 2 dihydrodiols
by different major pathways could provide
one explanation for the marked differences
in biological activity.
The K-region dihydrodiol, 4,5-dihydro-
4,5-dihydroxybenzo[a]pyrene, which can-
not be directly converted into a vicinal
diol-epoxide, since it does not possess an
isolated double bond adjacent to the
dihydrodiol grouping, was almost com-
pletely inactive as a mutagen when further
metabolized in the presence of S. typhi-
murium TAIOO (Malaveille et al., 1975),
failed to induce malignant transformation
at 3 dose levels in mouse fibroblasts
(Marquardt et al., 1976) and did not yield
detectable hydrocarbon-DNA products
when applied to mouse skin (Grover et al.,
1976). Consequently, it was somewhat
surprising to find that this 4,5-dihydrodiol
did initiate tumours in the present
experiments (Table I) and this aspect of
the results should perhaps be examined
further. It is of course possible that
metabolic activation of other regions of
the benzo[a]pyrene 4,5-dihydrodiol mole-
cules occurred in the initiation experi-
ments where 25 jig ofthis diol was applied
to each mouse but, if this is so, hydro-
carbon-DNA products might have been
expected to have been detected following
the application of 284,ug/mouse, but they
were not (Grover et al., 1976).
In many respects the present results
add further confirmation to the original
observation ofSims etal. (1974), who ident-
ified 7,8-dihydro-7,8-dihydroxybenzo[a]-
pyrene 9,10-oxide as the biologically
and chemically effective metabolite formed
from benzo[a]pyrene. This diol-epoxide
is now known to be a direct-acting muta-
gen in strains TA98 and TAlOO of S.
typhimurium (Wislocki et al., 1976) and in
V79 Chinese hamster cells in culture
(Wislocki et al., 1976; Huberman et al.,
1976). In the 2 in vitro systems in which
it has been tested for biological activity,
the 7,8-dihydrodiol proved to be more
active when metabolized than benzo[a]-
pyrene itself, but in the mouse skin
experiments reported here it was not
more active than the parent hydrocarbon.
The results of experiments in which
dihvdrodiols derived from benzo[a]pyrene
are now being tested for activity as
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complete carcinogens in vivo may help to
clarify the few anomalies that exist at
present regarding the metabolic activation
ofbenzo[a]pyrene.
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